Hero Banner

2024 Annual CMHC Call for Abstracts

CMHC Chairpersons George L. Bakris, MD, Christie M. Ballantyne, MD, Robert H. Eckel, MD, and Anne L. Peters, MD, invite you to submit scientific poster abstracts to be presented at the 2024 Cardiometabolic Health Congress (CMHC). 

Multidisciplinary clinicians from across the country will gather to discuss the most up-to-date developments in cardiometabolic health, including dyslipidemia, heart failure, hypertension, type 2 diabetes, weight management, and chronic kidney disease.

To enrich the attendee experience, we will offer scientific poster sessions to share the latest information from current research and clinical findings. Abstracts may be research-oriented or evidence-based practice that are relevant to frontline practitioners who treat patients with cardiometabolic disease.

Submit your abstract now and stay tuned for more information about which projects will be selected for publication in early 2025.

All individuals who require a visa to enter the United States are urged to immediately obtain necessary papers to attend the meeting upon submission of the abstract. A letter inviting any individual who wishes to attend may be obtained by emailing info@cardiometabolichealth.org. This letter does not imply any financial support by CMHC.

The abstract submission system will close at 5:00PM EST, Friday, September 13, 2024.

  • The abstract submission last date: Friday, September 13, 2024
  • Notification of abstract status Friday, September 20, 2024  
Abstracts Guidelines
  • Presenting author(s) or presenter(s) of accepted abstracts must register to attend the 2024 Annual CMHC. If your abstract is accepted, you will receive an exclusive link for complimentary meeting registration. Submission of an abstract does not automatically register you for the conference.
  • Abstracts may be of original research or encore (repeat) presentations of abstracts, i.e., CMHC will accept abstracts that have already been presented at other medical conferences.
  • Abstracts should be 900 words or less, with maximums as defined below. (Titles, author names, and affiliations are not included in the word count).
    • Purpose: 250 words
    • Methods: 250 words
    • Results: 300 words
    • Conclusions: 300 words
  • List affiliations for all authors, such as universities and other institutions.
  • List names of all authors, in the order in which you wish them to appear in printed text. One author listed must attend CMHC to present. Presenting author MUST provide their email address. No more than 10 authors should be listed.
  • List disclosures (financial and/or in-kind support). If none, state “Nothing to disclose by any author(s).”
  • Do not use tables, charts, or graphs in your abstract submission (they can be included in the actual poster).
  • There is no limit to the number of abstracts one author may submit for consideration.
  • The first author is responsible for communicating all of these policies to all involved parties.

CMHC requires faculty and poster authors/presenters who have an interest in selling a technology, program, product, and/or service to healthcare professionals to disclose this information in order to be considered for and/or present at any CMHC educational session.


If your abstract is accepted, you will be notified on or by Friday, September 20, 2024, and the abstracts will be posted on the CMHC website and our meeting conference guide. Only accepted abstracts will be posted. Click here to view our published abstracts from 2022 CMHC Annual.

Poster and Presentation Guidelines

Information coming soon.

Poster Setup

Information coming soon.

Late-Breaking Abstracts

The CMHC late-breaking abstracts policy allows for the submission of late-breaking abstracts only for randomized phase II and phase III trials for which no preliminary data are available at the time of the abstract submission deadline (September 13, 2024), but for which a preplanned analysis of the primary endpoint is scheduled after that date but before September 27, 2024 (deadline for the final, updated late-breaking abstract). During abstract submission, you will be required to provide the date of planned analysis. The policy is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline. Late-breaking abstracts must follow the same abstract guidelines listed on this page.


The abstract submission system will close at 5:00PM EST, Friday, September 13, 2024.


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.